biokriya
Chief Executive Officer Dr. Raj Iyer is an entrepreneurial biopharmaceutical executive with extensive US-APAC experience and core strengths in corporate strategy, business development and drug development operations. Prior to founding BioKriya, Raj was CBO at Porton Pharma Solutions / Porton Biologics and President, Arch Pharmalabs, where he played key roles in growing these CDMOs into global players. He serves on the Board at Gliding Eagle, a San Francisco-based supply chain data technology company and is an Investor and Board Advisor at Opal Oncology, Cambridge, England. Raj began his career as a CNS Drug Discovery scientist at Parke-Davis Warner Lambert and moved into positions of increasing responsibility in drug development at Merck KGaA and business development at Rhodia. He holds a Ph.D. in Analytical Biochemistry from George Washington University and was a Post-Doctoral Research Fellow in Neuroscience and Pharmacology at Yale University School of Medicine.
biokriya 